The G-protein coupled estrogen receptor, GPER: The inside and inside-out story

Molecular and Cellular Endocrinology

Volumn 418, Issue , 2015, Pages 207-219

  Gaudet, H M ^a   Cheng, S B ^b   Christensen, E M ^a   Filardo, E J ^b  

^a WHEATON COLLEGE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

G protein coupled receptor; GPER; Membrane estrogen receptor

Indexed keywords

ALDOSTERONE; ESTROGEN; G PROTEIN COUPLED RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; CELL RECEPTOR; ESTROGEN RECEPTOR; GPER PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; BONE REMODELING; BREAST CANCER; BREAST CARCINOGENESIS; CARDIOVASCULAR EFFECT; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL SELECTION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; ENDOCYTOSIS; ENDOSOME; ENERGY HOMEOSTASIS; ENERGY METABOLISM; HOMEOSTASIS; HORMONE ACTION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INTRACELLULAR MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RENAL PROTECTION; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; METABOLISM; PDZ DOMAIN; PROTEIN TRANSPORT;

ANIMALS; ENDOSOMES; HUMANS; INTRACELLULAR MEMBRANES; PDZ DOMAINS; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84949591872     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.07.016     Document Type: Article

References (169)

1. Adeyinka A., Nui Y., Cherlet T., Snell L., Watson P.H., Murphy L.C. Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin. Cancer Res. 2002, 8:1747-1753.
2. Ahola T.M., Purmonen S., Pennanen P., Zhuang Y.H., Tuohimaa P., Ylikomi T. Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells. Eur. J. Biochem. 2002, 269:2485-2490.
3. Aiad H.A., Wahed M.M., Asaad N.Y., El-Tahmody M., Elhosary E. Immunohistochemical expression of GPR30 in breast carcinoma of Egyptian patients: an association with immunohistochemical subtypes. APMIS 2014, 122:976-984.
4. Akama K.T., Thompson L.I., Milner T.A., McEwen B.S. Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines. J. Biol. Chem. 2013, 288:6438-6450.
5. Anchan D., Clark S., Pollard K., Vasudevan N. GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice. Brain Behav. 2014, 4:51-59.
6. Arias-Pulido H., Royce M., Gong Y., Joste N., Lomo L., Lee S.J., Chaher N., Verschraegen C., Lara J., Prossnitz E.R., Cristofanilli M. GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer. Breast Cancer Res. Treat. 2010, 123:51-58.
7. Balhuizen A., Kumar R., Amisten S., Lundquist I., Salehi A. Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice. Mol. Cell Endocrinol. 2010, 320:16-24.
8. Barrett K.V., McCurley A.T., Jaffe I.Z. Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation. Clin. Exp. Pharmacol. Physiol. 2013, 40:902-909.
9. Barton M., Meyer M.R., Prossnitz E.R. Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation. J. Cardiovasc. Pharmacol. 2013, 62:22-25.
10. Barton M., Prossnitz E.R. Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol. Metab. 2015, 26:185-192.
11. Batenburg W.W., Jansen P.M., van den Bogaerdt A.J., J Dansen A.H. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR and endothelial NO synthase. Cardiovasc. Res. 2012, 94:136-143.
12. Beck R., Rawet M., Wieland F.T., Cassel D. The COPI system: molecular mechanisms and function. FEBS Lett. 2009, 583:2701-2709.
13. Becuwe M., Herrador A., Haguenauer-Tsapis R., Vincent O., Léon S. Ubiquitin-mediated regulation of endocytosis by proteins of the arrestin family. Biochem. Res. Int. 2012, 242764.
14. Bian C., Zhu H., Zhao Y., Cai W., Zhang J. Intriguing roles of hippocampus-synthesized 17beta-estradiol in the modulation of hippocampal synaptic plasticity. J. Mol. Neurosci. 2014, 54:271-281.
15. Blasko E., Haskell C.A., Leung S., Gualtieri G., Halks-Miller M., Mahmoudi M., Dennis M.K., Prossnitz E.R., Karpus W.J., Horuk R. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J. Neuroimmunol. 2009, 214:67-77.
16. Brailoiu E., Dun S.L., Brailoiu G.C., Mizuo K., Sklar L.A., Oprea T.I., Prossnitz E.R., Dun N.J. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol. 2007, 193:311-321.
17. Broselid S., Berg K.A., Chavera T.A., Kahn R., Clarke W.P., Olde B., Leeb-Lundberg L.M. G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production. J. Biol. Chem. 2014, 289:22117-22127.
18. Carmeci C., Thompson D.A., Ring H.Z., Francke U., Weigel R.J. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997, 45:607-617.
19. Caroccia B., Seccia T.M., Campos A.G., Gioco F., Kuppusamy M., Ceolotto G., Guerzoni E., Simonato F., Mareso S., Lenzini L., Fassina A., Rossi G.P. GPER-1 and estrogen receptor-β ligands modulate aldosterone synthesis. Endocrinol 2014, 155:4296-4304.
20. Catalano S., Giordano C., Panza S., Chemi F., Bonofiglio D., Lanzino M., Rizza P., Romeo F., Fugua S.A., Maggiolini M., Ando S., Barone I. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth. Breast Cancer Res. Treat. 2014, 146:273-285.
21. Cheng S.B., Quinn J.A., Graeber C.T., Filardo E.J. Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-golgi-proteasome pathway. J. Biol. Chem. 2011, 286:22441-22455.
22. Cheng S.B., Graeber C.T., Quinn J.A., Filardo E.J. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 GPR30/GPER from the plasma membrane towards the nucleus. Steroids 2011, 76:892-896.
23. Cheng S.B., Filardo E.J. Trans-Golgi Network (TGN) as a regulatory node for β1-adrenergic receptor (β1AR) down-modulation and recycling. J. Biol. Chem. 2012, 287:14178-14191.
24. Cheng S.B., Dong J., Pang Y., LaRocca J., Hixon M., Thomas P., Filardo E.J. Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone. Mol. Cell Endocrinol. 2014, 382:950-959.
25. Chimento A., Casaburi I., Rosano C., Avena P., De Luca A., Campana C., Martire E., Santolla M.F., Maggiolini M., Pezzi V., Sirianni R. Oleuropein and hydroxytyrosol activate GPER/GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells. Mol. Nutr. Food Res. 2013, 58:478-489.
26. Connolly C.N., Uren J.M., Thomas P., Gorrie G.H., Gibson A., Smart T.G., Moss S.J. Cell surface stability of gamma-aminobutyric acid type A receptors. Dependence on protein kinase C activity and subunit composition. Mol. Cell Neurosci. 1999, 13:259-271.
27. Davis K.E., Carstens E.J., Irani B.G., Gent L.M., Hahner L.M., Clegg D.J. Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Horm. Behav. 2014, 66:196-207.
28. De Francesco E.M., Pellegrino M., Santolla M.F., Lappano R., Ricchio E., Abonante S., Maggiolini M. GPER mediates activation of HIFα/VEGF signaling by estrogens. Cancer Res. 2014, 74:4053-4064.
29. Deschamps A.M., Murphy E., Sun J. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc. Med. 2010, 20:73-78.
30. Ding Q., Gros R., Limbird L.E., Chorazyczewski J., Feldman R.D. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. Am. J. Physiol. Cell Physiol. 2009, 297:C1178-C1187.
31. Dong C., Filipeanu C.M., Duvernay M.T., Wu G. Regulation of G protein-coupled receptor export trafficking. Biochim. Biophys. Acta 2007, 1768:853-870.
32. Feldman R.D., Gros R. Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways. Br. J. Pharmacol. 2011, 163:1163-1169.
33. Feng Y., Gregor P. Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. Biochem. Biophys. Res. Commun. 1997, 231:651-654.
34. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
35. Filardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
36. Filardo E.J., Graeber C.T., Quinn J.A., Resnick M.B., Giri D., DeLellis R.A., Steinhoff M.M., Sabo E. Distribution of GPR30, a seven-membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathological determinants of tumor progression. Clin. Cancer Res. 2006, 12:6359-6366.
37. Filardo E.J., Quinn J., Pang Y., Graeber C., Shaw S., Dong J., Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinol 2007, 148:3236-3245.
38. Filardo E.J. GPER and ER: estrogen receptors with distinct biological roles in breast Cancer. Immunol. Endocr. Metab. Agents Med. Chem. 2011, 11:243-254.
39. Filardo E.J., Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinol 2012, 153:2953-2962.
40. Filipeanu C.M., Zhou F., Lam M.L., Kerut K.E., Claycomb W.C., Wu G. Enhancement of the recycling and activation of β-adrenergic receptor by Rab4 GTPase in cardiac myocytes. J. Biol. Chem. 2006, 281:11097-11103.
41. Ford J., Hajibeigi J., Long M., Hahner L., Gore C., Hsieh J.T., Clegg D., Zerkekh J., Oz O.K. GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice. J. Bone Min. Res. 2011, 26:298-307.
42. Fredette N.C., Meyer M., Prossnitz E.R. The G-protein coupled receptor (GPER/GPR30) activates endothelial nitric oxide synthase. FASEB J. 2014, 28(Suppl. 1). 1075.5.
43. Funakoshi T., Yanai A., Shinoda K., Kawano M.M., Mizukami Y. G protein- coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Comm. 2006, 346:904-910.
44. Funder J.W. GPR30, mineralocorticoid receptors, and the rapid vascular effects of aldosterone. Hypertension 2011, 57:370-372.
45. Gao F., Ma X., Ostmann A.B., Das S.K. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor α (ERα) phosphorylation signals. Endocrinol 2011, 152:1434-1447.
46. Gibbs R.B., Nelson D., Hammond R. Role of GPR30 in mediating estradiol effects on acetylcholine release in the hippocampus. Horm. Behav. 2014, 66:339-345.
47. Ginsberg M.H., Partridge A., Shattil S.J. Integrin regulation. Curr. Opin. Cell Biol. 2005, 17:509-516.
48. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986, 231:1150-1154.
49. Gros R., Ding Q., Liu B., Chorazyczewski J., Feldman R.D. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 2013, 304:C532-C540.
50. Haas E., Bhattacharya I., Brailou E., Bamjanovic M., Brailoiu G.C., Gao X., Mueller-Guerre L., Marjon N.A., Gut A., Minotti R., Meyer M.R., Amann K., Ammann E., Perez-Dominguez A., Genoni M., Clegg D.J., Dun N.J., Resta T.C., Prossnitz E.R., Barton M. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ. Res. 2009, 104:288-291.
51. Hammond R., Nelson D., Gibbs R.B. GPR30 co-localizes with cholinergic neurons in the basal forebrain and enhances potassium stimulated acetylcholine release in the hippocampus. Psychoneuroendocrinol 2011, 36:182-192.
52. Han G., Li F., Yu X., White R.E. GPER: a novel target for non-genomic estrogen action in the cardiovascular system. Pharmacol. Res. 2013, 71:53-60.
53. Hart D., Nilges M., Pollard K., Lynn T., Patsos O., Shiel C., Clark S.M., Vasudevan N. Activation of the G-protein coupled receptor 30 (GPR30) has different effects on anxiety in male and female mice. Steroids 2014, 81:49-56.
54. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12729-12734.
55. Hofmeister M.V., Damkier H.H., Christensen B.M., Olde B., Frederik Leeb-Lundberg L.M., Fenton A., Praetorius H.A., Praetorius J. 17β-estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1. Am. J. Physiol. Ren. Physiol. 2012, 302:F358-F368.
56. Howell A. The endocrine prevention of breast cancer. Best. Pract. Res. Clin. Endocrinol. Metab. 2008, 22:615-623.
57. Huang P., Chandra V., Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu. Rev. Physiol. 2010, 72:247-272.
58. Hussain Y., Ding Q., Connelly P.W., Brunt J.H., Ban M.R., McIntyre A.D., Huff M.W., Gros R., Hegele R.A., Feldman R.D. G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies. Arterioscler. Thomb Vasc. Biol. 2015, 35:213-221.
59. Hutchens M.P., Fujiyoshi T., Komers R., Herson P.S., Anderson S. Estrogen protects renal endotheial barrier function from ischemia-reperfusion in vitro and in vivo. Am. J. Physiol. Ren. Physiol. 2012, 303:F377-F385.
60. Hutchens M.P., Kosaka Y., Zhang W., Fujiyoshi T., Murphy S., Alkayed N., Anderson S. Estrogen-mediated renoprotection following cardiac arrest and cardiopulmonary resuscitation is robust to GPR30 gene deletion. PLoS One 2014, 9:e99910.
61. Ignatov T., Eggemann H., Semczuk A., Smith B., Bischoff J., Roessner A., Costa S.D., Kalinski T., Ignatov A. Role of GPR30 in endometrial pathology after tamoxifen for breast cancer. Am. J. Obstet. Gynecol. 2010, 595:e9-16.
62. Ignatov T., Weissenborn C., Poehlmann A., Lemke A., Semczuk A., Roessner A., Costa S.D., Kalinski T., Ignatov A. GPER-1 expression decreases during breast cancer tumorigenesis. Cancer Invest. 2013, 31:309-315.
63. Innamorati G., Le Gouill C., Balamotis M., Birnbaumer M. The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors. J. Biol. Chem. 2001, 276:13096-13103.
64. Irannejad R., von Zastrow M. GPCR signaling along the endocytic pathway. Curr. Opin. Cell Biol. 2014, 27:109-116.
65. Isensee J., Meoli L., Zazzu V., Nabzdyk C., Witt H., Soewarto D., Effertz K., Fuchs H., Gailus-Durner V., Busch D., Adler T., de Angelis M.H., Irgang M., Otto C., Noppinger P.R. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinol 2009, 150:1722-1730.
66. Jean-Alphonse F., Hanyaloglu A.C. Regulation of GPCR signal networks via membrane trafficking. Mol. Cell Endocrinol. 2011, 331:205-214.
67. Kanda N., Watanabe S. 17beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. J. Invest. Dermatol. 2003, 121:1500-1509.
68. Kastenberger I., Schwarzer C. GPER1 (GPR30) knockout mice display reduced anxiety and altered stress response in a sex and paradigm dependent manner. Horm. Behav. 2014, 66:628-636.
69. Kim K.H., Toomre D., Bender J.R. Splice isoform estrogen receptors as integral transmembrane proteins. Mol. Biol. Cell. 2011, 22:4415-4423.
70. Kim K.H., Young B.D., Bender J.R. Endothelial estrogen receptor isoforms and cardiovascular disease. Mol. Cell. Endocrinol. 2014, 389:65-70.
71. Kimura M., Mizukami Y., Miura T., Fujimoto K., Kobayashi S., Matsuzaki M. Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation. J. Biol. Chem. 2001, 276:26453-26560.
72. Kosaka Y., Quillinan N., Bond C., Traystman R., Hurn P., Herson P. GPER1/GPR30 activation improves neuronal survival following global cerebral ischemia induced by cardiac arrest in mice. Transl. Stroke Res. 2012, 3:500-507.
73. Kotowski S.J., Hopf F.W., Seif T., Bonci A., von Zastrow M. Endocytosis promotes rapid dopaminergic signaling. Neuron 2011, 71:278-290.
74. Kumar R., Balhuizen A., Amisten S., Lundquist I., Salehi A. Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets. Endocrinol 2011, 152:2568-2579.
75. Kvingedal A.M., Smeland E.B. A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett. 1997, 407:59-62.
76. Lafferty A., Torpy D., Stowasser M., Taymans S., Lin J.P., Huggard P., Gordon R., Stratakis C. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J. Med. Genet. 2000, 37:831-835.
77. Lappano R., Rosano C., De Marco P., De Francesco E.M., Pezzi V., Maggiolini M. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol. Cell Endocrinol. 2010, 320:162-170.
78. Lappano R., Pisano A., Maggiolini M. GPER function in breast Cancer: an overview. Front. Endocrinol. (Lausanne) 2014, 5:66.
79. Lebesgue D., Traub M., De Butte-Smith M., Chen C., Zukin R.S., Kelly M.J., Etgen A.M. Acute administration of non- classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One 2010, 5:e8642.
80. Lee T.M., Lin S.Z., Chang N.C. Both GPER and membrane oestrogen receptor-α activation protect ventricular remodelling in 17β oestradiol-treated ovariectomized infarcted rats. J. Cell Mol. Med. 2014, 18:2454-2465.
81. Lenhart P.M., Broselid S., Barrick C.J., Leeb-Lundberg L.M., Caron K.M. G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J. Mol. Endocrinol. 2013, 51:191-202.
82. Leterrier C., Bonnard D., Carrel D., Rossier J., Lenkei Z. Constitutive endocytic cycle of the CB1 cannabinoid receptor. J. Biol. Chem. 2004, 279:36013-36021.
83. Levin E.R. Extranuclear steroid receptors are essential for steroid hormone actions. Annu. Rev. Med. 2015, 66:271-280.
84. Li F., Yu X., Szynkarski C.K., Meng C., Zhou B., Barhoumi R., White R.E., Heaps C.L., Stallone J.N., Han G. Activation of GPER induces differentiation and inhibition of coronary artery smooth muscle cell proliferation. PLoS One 2013, 8:e64771.
85. Li L., Haynes M.P., Bender J.R. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4807-4812.
86. Lin Y., Smrcka A.V. Understanding molecular recognition by G protein βγ subunits on the path to pharmacological targeting. Mol. Pharmacol. 2011, 80:551-557.
87. Lindsey S.H., Chappell M.C. Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen. Gend. Med. 2011, 8:343-354.
88. Lindsey S.H., Yamaleyeva L.M., Brosnihan K.B., Gallagher P.E., Chappell M.C. Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension 2011, 58:665-671.
89. Lindsey S.H., Liu L., Chappell M.C. Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling. Steroids 2014, 81:99-102.
90. Liu S., Le May C., Wong W.P., Ward R.D., Clegg D.J., Marcelli M., Korach K.S., Mauvais-Jarvis F. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 2009, 58:2292-2302.
91. Lohse M.J., Engelhardt S., Eschenhagen T. What is the role of β-adrenergic signaling in heart failure?. Circ. Res. 2003, 93:896-906.
92. Long L., Cao Y., Tang L.D. Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression. Int. J. Gynecol. Cancer 2012, 22:539-545.
93. Lother A., Moser M., Bode C., Feldman R.D., Hein L. Mineralocorticoids in the heart and vasculature: new insights for old hormones. Annu. Rev. Pharmacol. Toxicol. 2015, 55:289-312.
94. Lu M., Echeverri F., Moyer B.D. Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors. Traffic 2003, 4:416-433.
95. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Ann. Rev. Immunol. 2007, 25:619-647.
96. Maggiolini M., Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J. Endocrinol. 2010, 204:105-114.
97. Magruder H.T., Quinn J.A., Schwartzbauer J.E., Reichner J., Huang A., Filardo E.J. The G protein-coupled estrogen receptor-1, GPER-1, promotes fibrillogenesis via a shc-dependent pathway resulting in anchorage-independent growth. Horm. Cancer 2014, 5:390-404.
98. Maiti K., Paul J.W., Read M., Chan E.C., Riley S.C., Nahar P., Smith R. G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium. Endocrinol 2011, 152:2448-2455.
99. Marchese A., Paing M.M., Temple B.R., Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 2008, 48:601-629.
100. Marjon N.A., Hu C., Hathaway H.J., Prossnitz E.R. G protein-coupled estrogen receptor (GPER) regulates mammary tumorigenesis and metastasis. Mol. Cancer Res. 2014, 12:1644-1654.
101. Mårtensson U.E., Salehi S.A., Windahl S., Gomez M.F., Swärd K., Daszkiewicz-Nilsson J., Wendt A., Andersson N., Hellstrand P., Grände P.O., Owman C., Rosen C.J., Adamo M.L., Lundquist I., Rorsman P., Nilsson B.O., Ohlsson C., Olde B., Leeb-Lundberg L.M. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinol 2009, 150:687-698.
102. Meyer M.R., Clegg D.J., Prossnitz E.R., Barton M. Obesity, insulin-resistance, and diabetes: sex differences and role of oestrogen receptors. Acta Physiol. (Oxf) 2011, 203:259-269.
103. Meyer M.R., Prossnitz E.R., Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vasc. Pharmacol. 2011, 55:17-25.
104. Meyer M.R., Field A.S., Kanagy N.L., Barton M., Prossnitz E.R. GPER regulates endothelin-dependent vascular tone and intracellular calcium. Lif. Sci. 2012, 91:623-627.
105. Meyer M.R., Fredette N.C., Howard T.A., Hu C., Ramesh C., Daniel C., Amann K., Arterburn J.B., Barton M., Prossnitz E.R. G protein-coupled estrogen receptor protects from atheroscherosis. Sci. Rep. 2014, 4:7564.
106. Michaelson D., Ahearn I., Bergo M., Young S., Philips M. Membrane trafficking of heterotrimeric G proteins via the endoplasmic reticulum and golgi. Mol. Biol. Cell. 2004, 13:3294-3302.
107. Morisco C., Marrone C., Galeotti J., Shao D., Vatner D.E., Vatner S.F., Sadoshima J. Endocytosis machinery is required for β1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes. Cardiovasc. Res. 2008, 78:36-44.
108. Mueller H., Flury N., Eppenberger-Castori S., Kueng W., David F., Eppenberger U. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients. Int. J. Cancer 2000, 89:384-388.
109. Neugarten J., Acharya A., Silbiger S.R. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J. Am. Soc. Nephrol. 2000, 11:319-329.
110. Nilsson B.O., Olde B., Leeb-Lundberg L.M. G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signaling. Br. J. Parmacol. 2011, 163:1131-1139.
111. Noel S.D., Keen K.L., Baumann D.I., Filardo E.J., Terasawa E. Involvement of G protein-coupled receptor 30 (GPR30) in rapid action of estrogen in primate LHRH neurons. Mol. Endocrinol. 2009, 23:349-359.
112. O'Dowd B.F., Nguyen T., Marchese A., Cheng R., Lynch K.R., Heng H.H., Kolakowski L.F., George S.R. Discovery of three novel G-protein-coupled receptor genes. Genomics 1998, 47:310-313.
113. Ohlsson C., Vandenput L. The role of estrogens for male bone health. Eur. J. Endocrinol. 2009, 160:883-889.
114. Olde B., Leeb-Lundberg L.M. GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol. Metab. 2009, 20:409-416.
115. Owman C., Blay P., Nilsson C., Lolait S.J. Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem. Biophys. Res. Commun. 1996, 228:285-292.
116. Pang Y., Dong J., Thomas P. Estrogen signaling characteristics of Atlantic croaker GPR30 and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinol 2008, 149:3410-3426.
117. Patel V.H., Chen J., Ramanjaneya M., Karteris E., Zachariades E., Thomas P., Been M., Randeva H.S. G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischemic stress. Int. J. Mol. Med. 2010, 26:193-199.
118. Pedram A., Razandi M., Sainson R.C., Kim J.K., Hughes C.C., Levin E.R. A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 2007, 282:22278-22288.
119. Petrie W.K., Dennis M.K., Hu C., Dai D., Arterburn J.B., Smith H.O., Hathaway H.J., Prossnitz E.R. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstet. Gynecol. Int. 2013, 2013:472720.
120. Peyton C., Thomas P. Involvement of epidermal growth factor receptor signaling in estrogen inhibition of oocyte maturation mediated through the G protein-coupled estrogen receptor (GPER) in zebrafish (Danio rerio). Biol. Reprod. 2011, 85:42-50.
121. Prat A., Perou C.M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 2011, 5:5-23.
122. Prossnitz E.R., Barton M. Estrogen biology: new insights into GPER function and clinical opportunities. Mol. Cell Endocrinol. 2014, 389:71-83.
123. Prossnitz E.R., Arterburn J.B. G protein-coupled estrogen receptor (GPER) and its pharmacologic modulators. Pharm. Rev. Pharmacol. Rev. 2015, 67:505-540.
124. Pruthi D., McCurley A., Aronovitz M., Galayda C., Karumanchi S.A., Jaffe I.Z. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Arterioscler. Thromb. Vasc. Biol. 2014, 34:355-364.
125. Puca L., Brou C. α-arrestins- new players in Notch and GPCR signaling pathways in mammals. J. Cell Sci. 2014, 127:1359-1367.
126. Qiu J., Bosch M.A., Tobias S.C., Krust A., Graham S.M., Murphy S.J., Korach K.S., Chambon P., Scanlan T.S., Rønnekleiv O.K., Kelly M.J.A. G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. J. Neurosci. 2006, 26:5649-5655.
127. Quinn J.A., Graeber C.T., Frackelton A.R., Kim M., Schwarzbauer J.E., Filardo E.J. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30. Mol. Endocrinol. 2009, 23:1052-1064.
128. Ramesh C., Nayak T.K., Burai R., Dennis M.K., Hathaway H.J., Sklar L.A., Prossnitz E.R., Arterburn J.B. Synthesis and characterization of iodinated tetrahydroquinolines targeting the G-protein coupled estrogen receptor GPR30. J. Med. Chem. 2010, 53:1004-1014.
129. Razandi M., Pedram A., Park S.T., Levin E.R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 2003, 278:2701-2712.
130. Ren Y., D'Ambrosio M.A., Garvin J.L., Leung P., Kutskill K., Wang H., Peterson E.L., Carretero O.A. Aldosterone sensitizes connecting tubule glomerular feedback via the aldosterone receptor GPR30. Am. J. Physiol. Ren. Physiol. 2014, 307:F427-F434.
131. Rettew J.A., McCall S.H., Marriott I. GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Mol. Cell Endocrinol. 2010, 329:87-92.
132. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
133. Revankar C.M., Mitchell H.D., Field A.S., Burai R., Corona C., Ramesh C., Sklar L.A., Arterburn J.B., Prossnitz E.R. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol. 2007, 2:536-544.
134. Ropero A.B., Pang Y., Alonso-Magdalena P., Thomas P., Nadal A. Role of ERbeta and GPR30 in the endocrine pancreas: a matter of estrogen dose. Steroids 2012, 77:951-958.
135. Sandén C., Broselid S., Cornmark L., Andersson K., Daszkiewicz-Nilsson J., Mårtensson U.E., Olde B., Leeb-Lundberg L.M. G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol. Pharmacol. 2011, 79:400-410.
136. Scita G., Di Fiore P.P. The endocytic matrix. Nature 2010, 463:464-473.
137. Seifert R., Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedeb. Arch. Pharmacol. 2002, 366:381-416.
138. Shenoy S.K., Lefkowitz R.J. β-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol. Sci. 2011, 32:521-533.
139. Sharma G., Prossnitz E.R. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinol 2011, 152:3030-3039.
140. Sharma G., Hu C., Brigman J.L., Zhu G., Hathaway H.J., Prossnitz E.R. GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinol 2013, 154:4136-4145.
141. Shi Y., Liu X., Zhu P., Li J., Sham K.W., Cheng S.H., Li S., Zhang Y., Cheng C.H., Lin H. G protein coupled estrogen receptor 1 is involved in brain development during zebrafish (danio rerio) embryogenesis. Biochem. Biophys. Res. Commun. 2013, 435:21-27.
142. Sivaraman V.S., Wang H., Nuovo G.J., Malbon C.C. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 1997, 99:1478-1483.
143. Smith H.O., Leslie K.K., Singh M., Qualls C.R., Revankar C.M., Joste N.E., Prossnitz E.R. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 2007, 196:386. e1-9.
144. Smith H.O., Arias-Pulido H., Kuo D.Y., Howard T., Qualls C.R., Lee S.J., Verschraegen C.F., Hathaway H.J., Joste N.E., Prossnitz E.R. GPR30 predicts poor survival for ovarian cancer. Gynecol. Oncol. 2009, 114:465-471.
145. Spary E.J., Chapman S.E., Sinfield J.K., Maqbool A., Kaye J., Batten T.F. Novel G protein-coupled oestrogen receptor GPR30 shows changes in mRNA expression in the rat brain over the oestrous cycle. Neurosignals 2013, 21:14-27.
146. Steiman J., Peralta E.A., Louis S., Kamel O. Biology of the estrogen receptor, GPR30, in triple negative breast cancer. Am. J. Surg. 2013, 206:698-703.
147. Stein R.S., Ehlert F.J. A kinetic model of GPCRs: analysis of G protein activity, occupancy, coupling and receptor-state affinity constants. J. Recept Signal Transduct. Res. 2014, 29:1-15.
148. Sukor N., Mulatero P., Gordon R.D., So A., Duffy D., Bertello C., Kelemen L., Jeske Y., Veglio F., Stowasser M. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J. Hypertens. 2008, 26:1577-1582.
149. Sykes D.A., Riddy D.M., Stamp C., Bradley M.E., McGuiness N., Sattikar A., Guerini D., Rodrigues I., Glaenzel A., Dowling M.R., Mullershausen F., Charlton S.J. Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization. Br. J. Pharmacol. 2014, 171:4797-4807.
150. Szego C.M., Davis J.S. Adenosine 30,50-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. U. S. A. 1967, 58:1711-1718.
151. Takada Y., Kato C., Kondo S., Korenaga R., Ando J. Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem. Biophys. Res. Commun. 1997, 240:737-741.
152. Tang H., Zhang Q., Yang L., Dong Y., Khan M., Yang F., Brann D.W., Wang R. Reprint of "GPR30 mediates estrogen rapid signaling and neuroprotection". Mol. Cell Endocrinol. 2014, 389:92-98.
153. Tarasova N.I., Stauber R.H., Choi J.K., Hudson E.A., Czerwinski G., Miller J.L., Pavlakis G.N., Michejda C.J., Wank S.A. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J. Biol. Chem. 1997, 272:14817-14824.
154. Teng J., Wang Z.Y., Prossnitz E.R., Bjorling D.E. The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation. Endocrinol 2008, 149:4024-4034.
155. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of a membrane estrogen receptor coupled to a G-protein in human breast cancer cells. Endocrinol 2005, 146:624-632.
156. Tiano J., Mauvais-Jarvis F. Selective estrogen receptor modulation in pancreatic B-cells and the prevention of type 2 diabetes. Islets 2012, 4:173-176.
157. Tohgo A., Choy E.W., Gesty-Palmer D., Pierce K.L., Laporte S., Oakley R.H., Caron M.G., Lefkowitz R.J., Luttrell L.M. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem. 2003, 278:6258-6267.
158. Tran Q.-K., VerMeer M., Burgard M.A., Hassan A.B., Giles J. Hetero-oligomeric complex between the G protein-coupled estrogen receptor 1 and the plasma membrane Ca2+-ATPase 4b. J. Biol. Chem. 290, 2015, 10.1074/jbc.M114.628743.
159. Vitale C., Mendelsohn M.E., Rosano G.M. Gender differences in the cardiovascular effect of sex hormones. Nat. Rev. Cardiol. 2009, 6:532-542.
160. Wang C., Prossnitz E.R., Roy S.K. Expression of G protein-coupled receptor 30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones. Endocrinol 2007, 148:4853-4864.
161. Wehbi V.L., Stevenson H.P., Feinstein T.N., Calero G., Romero G., Vilardaga J.P. Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gβγ complex. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:1530-1535.
162. Wells G.J. Editorial: allosteric modulators of G protein-coupled receptors. Curr. Top. Med. Chem. 2014, 14:1735-1737.
163. Werthmann R.C., Volpe S., Lohse M.J., Calebiro D. Persistent cAMP signaling by internalized TSH receptors occurs in thyroid but not in HEK293 cells. FASEB J. 2012, 26:2043-2048.
164. Windahl S.H., Andersson N., Chagin A.S., Martensson U.E., Carlsten H., Olde B., Swanson C., Moverare-Skrtic S., Savendahl L., Lagerquist M.K., Leeb-Lundberg L.M., Ohlsson C. The role of G protein-coupled receptor GPR30 in the effects of estrogen in ovarectomized mice. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E490-E496.
165. Wyckoff M.H., Chambliss K.L., Mineo C., Yuhanna I.S., Mendelsohn M.E., Mumby S.M., Shaul P.W. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). J. Biol. Chem. 2001, 276:27071-27076.
166. Xu H., Qin S., Carrasco G.A., Dai Y., Filardo E.J., Prossnitz E.R., Battaglia G., Doncarlos L.L., Muma N.A. Neuroscience 2009, 158:1599-1607.
167. Yu T., Liu M., Luo H., Wu C., Tang X., Tang S., Hu P., Yan Y., Wang Z., Tu G. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17beta-estradiol in triple-negative breast cancer cells. J. Steroid Biochem. Mol. Biol. 2014, 142:392-403.
168. Yu C., Li F., Klussmann E., Stallone J.N., Han G. G protein-coupled estrogen receptor 1 mediates relaxation of coronary arteries via cAMP/PKA-dependent activation of MLCP. Am. J. Physiol. Endocrinol. Metab. 2014, 307:E398-E407.
169. Zhang Y., Foudi A., Geay J.F., Berthebaud M., Buet D., Jarrier P., Jalil A., Vainchenker W., Louache F. Stem Cells 2004, 22:1015-1029.